Get ready for the genomic revolution
Prostate cancer is a recognised component of the hereditary breast and ovarian cancer (HBOC) syndrome cancer spectrum, where inherited susceptibility is accounted for by mutations in BRCA1 and BRCA2 genes. Genetic testing for BRCA1/2 mutations may provide some men with information about their risk for developing aggressive prostate cancer…
Source: Trends in Urology, Gynaecology and Sexual Health - Category: OBGYN Authors: Roger Kirby Tags: Editorial Source Type: research
More News: Cancer | Cancer & Oncology | Genetics | OBGYN | Ovarian Cancer | Ovaries | Prostate Cancer | Urology & Nephrology